ROPINIROLE KRKA 4 mg PROLONGED-RELEASE TABLETS

2. What you need to know before you take Ropinirol Krka

Do not take Ropinirol Krka if:

• you are allergic to ropinirole or any of the other ingredients of this medicine (listed in section 6),
• you have severe kidney disease,
• you have liver disease.

Tell your doctor if you think you may have any of these conditions.

Warnings and precautions

Consult your doctor or pharmacist before taking Ropinirol Krka

• if you are pregnant or think you may be pregnant,
• if you are breast-feeding,
• if you are under 18 years old,
• if you have severe heart disease,
• if you have severe mental health problems,
• if you have impulse control disorders and/or abnormal behaviour (see section 4)
• if you have intolerance to some sugars (e.g. lactose).

Tell your doctor if you think you may have any of these conditions. Your doctor will decide if your treatment with Ropinirol Krka is suitable for you, or if you need closer monitoring while taking it.

Tell your doctor if you or your family/carer notice that you are developing unusual behaviours, such as an unusual urge to gamble, increased sexual urges, or uncontrolled spending. Your doctor may need to adjust or stop your treatment.

Tell your doctor if you notice symptoms such as depression, apathy, anxiety, fatigue, sweating, or pain when stopping or reducing treatment with ropinirole (called dopamine agonist withdrawal syndrome or DAWS). If problems persist after a few weeks, your doctor may need to adjust your treatment.

Tell your doctor if you or your family/carer notice that you are developing episodes of mania (euphoria or irritability). These can occur with or without impulse control disorders (see above). Your doctor may need to adjust or stop your treatment.

While taking Ropinirol Krka

Tell your doctor if you or your family notice that you are developing unusual behaviours (such as an unusual urge to gamble or increased sexual urges) while taking Ropinirol Krka. Your doctor may need to adjust or stop your treatment.

Smoking and Ropinirol Krka

Tell your doctorif you start or stop smoking while taking Ropinirol Krka.

Your doctor may need to adjust your dose.

Other medicines and Ropinirol Krka

Tell your doctor or pharmacist if you are taking, have recently taken, or might take any other medicines, including those obtained without a prescription.

Remember to tell your doctor or pharmacist if you start taking a new medicine while taking Ropinirol Krka.

Some medicines may affect the way ropinirole works, or make it more likely that you will get side effects. Ropinirole may also affect the way other medicines work.

These medicines include:

• the antidepressant fluvoxamine,
• medicines for mental health problems, such as sulpiride,
• hormone replacement therapy (also called HRT),
• metoclopramide, used to treat nausea and stomach acid,
• the antibiotics ciprofloxacin or enoxacin,
• any other medicine for Parkinson's disease.

Tell your doctor if you are taking, or have recently taken, any of these medicines.

You will need to have extra blood testsif you are taking these medicines with Ropinirol Krka:

• Vitamin K antagonists (used to prevent blood clotting) such as warfarin (Coumadin).

Taking Ropinirol Krka with food, drinks and alcohol

You can take Ropinirol Krka with or without food.

Pregnancy and breast-feeding

Ropinirol should not be used during pregnancy unless your doctor advises that the benefits outweigh the risks to the unborn baby. Ropinirol should not be used during breast-feeding as it may affect milk production.

If you are pregnant or breast-feeding, think you may be pregnant or are planning to have a baby, ask your doctor or pharmacist for advice before taking this medicine. Your doctor will recommend what you should do if you are breast-feeding or think you may be pregnant. Your doctor may recommend that you stop taking Ropinirol Krka.

Driving and using machines

Ropinirol Krka may make you feel drowsy. In rare cases, Ropinirol Krka may make you feel extremely drowsy, and you may fall asleep suddenly without warning.

If this happens: do not drive, do not use machines, and do notput yourself in situations where feeling drowsy or falling asleep could put you or others at risk of serious harm or death. Do not engage in these activities until you are no longer affected.

Ropinirol Krka contains lactose

This medicine contains lactose. If your doctor has told you that you have an intolerance to some sugars, contact them before taking this medicine.

3. How to take Ropinirol Krka

Take this medicine exactly as your doctor or pharmacist has told you. If you are not sure, ask your doctor or pharmacist.

Use in children and adolescents

Do not give Ropinirol Krka to children.Ropinirole is not normally prescribed for people under 18 years old.

You may have been prescribed ropinirole on its own to treat your Parkinson's disease symptoms, or you may have been prescribed ropinirole as well as another medicine called L-dopa (also known as levodopa). If you are taking L-dopa, you may experience some uncontrollable movements (dyskinesias) when you first start taking ropinirole. If this happens, talk to your doctor, as they may need to adjust the doses of the medicines you are taking.

Ropinirol Krka tablets are designed to release the active substance over a 24-hour period. If you have a condition that makes the medicine pass through your body too quickly, such as diarrhoea, the tablets may not work properly. You may see the tablets in your stools. If this happens, tell your doctor as soon as possible.

What dose of Ropinirol Krka should you take?

It may take some time to find the best dose of ropinirole for you.

The recommended starting doseof ropinirole prolonged-release tablets is 2 mg once a day for the first week. After this, your doctor may increase the dose to 4 mg of ropinirole prolonged-release tablets once a day, during the second week of treatment. In elderly people, the doctor may increase the dose more slowly. After this, your doctor may adjust the dose to the best level for you. Some people may take up to 24 mg of ropinirole prolonged-release tablets each day.

If you experience side effects that you cannot tolerate when you first start treatment, talk to your doctor. Your doctor may advise you to switch to a lower dose of ropinirole immediate-release tablets, which you would take three times a day.

Do not take more Ropinirol Krka tablets than your doctor has recommended.

It may take several weeks for ropinirole to start working.

How to take your dose of Ropinirol Krka

Take Ropinirol Krka once a day, at the same time each day.

Do not break, chew or crushthe prolonged-release tablets. If you do, you may be at risk of getting too much medicine at once, because the medicine will be released into your body too quickly.

If you switch from ropinirole immediate-release tablets

Your doctor will adjust your dose of ropinirole prolonged-release tablets based on the dose of ropinirole immediate-release tablets you are taking.

Take your ropinirole immediate-release tablets as usual on the day before you switch. Then, take your ropinirole prolonged-release tablets the next morning, and do not take any more ropinirole immediate-release tablets.

If you take more Ropinirol Krka than you should

If you have taken more ropinirole than you should, talk to a doctor or go to a hospital casualty department straight away, or call the Poisons Information Service on 91 562 04 20, quoting the name of the medicine and the amount you have taken. If possible, show them the pack.

Someone who has taken too much ropinirole may experience some of the following symptoms: nausea, vomiting, dizziness, drowsiness, fatigue, feeling faint, hallucinations.

If you forget to take Ropinirol Krka

Do not take extra tablets or a double dose to make up for a forgotten dose.

If you have forgotten to take Ropinirol Krka for one or more days, talk to your doctor to find out how to start taking it again.

If you stop taking Ropinirol Krka

Do not stop taking Ropinirol Krka without talking to your doctor.

Take Ropinirol Krka for as long as your doctor recommends. Do not stop taking Ropinirol Krka unless your doctor tells you to.

If you stop taking Ropinirol Krka suddenly, your Parkinson's disease symptoms may get much worse very quickly.

Do not stop taking Ropinirol Krka suddenly without talking to your doctor.

Suddenly stopping Ropinirol Krka may cause a condition called neuroleptic malignant syndrome, which can be life-threatening. The symptoms are: muscle stiffness, fever, unstable blood pressure, a fast heart rate, confusion, reduced consciousness (e.g. coma).

If you need to stop taking Ropinirol Krka, your doctor will reduce your dose gradually.

If you have any further questions on the use of this product, ask your doctor or pharmacist.

4. Possible side effects

Like all medicines, this medicine can cause side effects, although not everybody gets them.

Ropinirol Krka side effects are most likely to happen when you first start taking the medicine, or when your dose is increased. These are usually mild and may become less troublesome after a while. If you are concerned about side effects, talk to your doctor.

Very common side effects (may affect more than 1 in 10 people):

• feeling faint,
• drowsiness,
• nausea.

Common side effects (may affect up to 1 in 10 people):

• falling asleep suddenly without feeling sleepy beforehand (sudden sleep episodes),

• hallucinations (seeing things that are not really there),
• vomiting,
• dizziness,
• heartburn,
• stomach pain,
• constipation,
• swelling of the legs, feet or hands.

Uncommon side effects (may affect up to 1 in 100 people):

• dizziness or fainting, especially when standing up quickly (this is due to low blood pressure),
• low blood pressure (hypotension),

• feeling very drowsy during the day (excessive daytime somnolence),
• mental problems such as delirium (severe confusion), delusional thoughts (irrational thoughts) or paranoia (irrational suspicions),
• hypo.

Some patients may have the following side effects(frequency not known: cannot be estimated from the available data):

• allergic reactions such as redness, skin inflammation with itching (urticaria), swelling of the face, lips, mouth, tongue or throat which may cause difficulty in swallowing or breathing, rash or intense itching (see section 2),

• changes in liver function, which can be detected with blood tests,
• aggressive behaviour,
• excessive use of Ropinirol Krka (anxiety to take more doses of dopaminergic medicines than needed to control motor symptoms, known as dopamine dysregulation syndrome),
• inability to resist the impulse to perform an action that could be harmful, which may include:
• an unusual urge to gamble to the point where it causes serious personal or family problems,
• a significant increase in sexual desire or behaviour that causes concern to you or others, such as an increased libido,
• compulsive shopping,
• binge eating (eating large amounts of food in a short time) or compulsive eating (eating more than normal and more than needed to satisfy your appetite).
• after stopping or reducing treatment with Ropinirol Krka: depression, apathy, anxiety, fatigue, sweating, or pain (known as dopamine agonist withdrawal syndrome or DAWS),
• episodes of excessive excitement, euphoria or irritability.
• spontaneous penile erection.

Tell your doctor if you get any of these side effects, they will discuss ways to manage or reduce them.

If you are taking ropinirole with L-dopa

People taking ropinirole with L-dopa may develop additional side effects after some time:

• uncontrollable movements (dyskinesias) are a very common side effect. If you are taking L-dopa, you may experience some uncontrollable movements (dyskinesias) when you first start taking ropinirole. If this happens, talk to your doctor, as they may need to adjust the doses of the medicines you are taking,
• a common side effect is confusion.

Reporting of side effects

If you get any side effects, talk to your doctor or pharmacist. This includes any possible side effects not listed in this leaflet. You can also report side effects directly via the Spanish Medicines Information System: www.notificaram.es. By reporting side effects, you can help provide more information on the safety of this medicine.

5. Storing Ropinirol Krka

Keep this medicine out of the sight and reach of children.

Do not use this medicine after the expiry date which is stated on the carton and blister after EXP. The expiry date refers to the last day of that month.

Do not store above 30°C.

Store in the original package to protect from moisture.

Medicines should not be disposed of via wastewater or household waste. Ask your pharmacist how to dispose of medicines no longer required. These measures will help protect the environment.

6. Packaging Contents and Additional Information

Composition of Ropinirol Krka 4 mg prolonged-release tablets

• The active substance is ropinirol. Each prolonged-release tablet contains 4 mg of ropinirol (as hydrochloride).

• The other ingredients are:

Tablet core:hypromellose 2208, lactose monohydrate, colloidal anhydrous silica, carbomer 4,000-11,000 mPa.s, hydrogenated castor oil, magnesium stearate. Coating:hypromellose 2910, titanium dioxide (E171), macrogol 400, red iron oxide (E172), yellow iron oxide (E172), black iron oxide (E172). See section 2 "Ropinirol Krka contains lactose".

Appearance and Packaging of the Product

Ropinirol Krka 4 mg are light brown, biconvex, and oval prolonged-release tablets.

The tablets are available in packs of 10, 21, 28, 30, 42, 60, 84, and 90 prolonged-release tablets in blisters (OPA/Al/PVC//Al).

Only some pack sizes may be marketed.

Marketing Authorisation Holder and Manufacturer

Marketing Authorisation Holder:

KRKA, d.d., Novo mesto, Šmarješka cesta 6, 8501 Novo mesto, Slovenia

Manufacturer:

KRKA, d.d., Novo mesto, Šmarješka cesta 6, 8501 Novo mesto, Slovenia

or

TAD Pharma GmbH, Heinz-Lohmann-Straße 5, 27472 Cuxhaven, Germany

Further information about this medicinal product can be obtained from the local representative of the Marketing Authorisation Holder:

KRKA Farmacéutica, S.L., C/ Anabel Segura 10, Pta. Baja, Oficina 1, 28108 Alcobendas, Madrid, Spain

This medicinal product is authorised in the Member States of the European Economic Area under the following names:

Date of last revision of this leaflet: July 2023

Detailed information on this medicinal product is available on the website of the Spanish Agency for Medicines and Health Products (AEMPS) http://www.aemps.gob.es/)